The pleiotropic actions of TGF-b as a mediator of immune homeostasis and tolerance, inducer of EMT and ECM, as well as a promoter of tumor immune evasion, complicate interpretation of the influence of the TGF-b pathway on cancer progression [66]. This evidence concerns the gene TGFB1 and cancer.